February 6, 2012
GE is investing in strong corporate and employment branding. During last night’s Super Bowl telecast, there we noticed at least three GE commercials, one centered on GE Healthcare. The 30-second commercial was based on this longer video from GE Healthcare, with cancer survivors meeting the folks involved with GE’s equipment. The other GE commercials [...]
Read the full article →
February 3, 2012
The New England Patriots and New York Giants will both be looking for game-changing plays this weekend in Super Bowl XLVI. It seems the medical device industry may have a game-changer of its own in the works. The FDA and representatives from the medical device industry have reached an agreement in principle on proposed recommendations [...]
Read the full article →
February 3, 2012
Secretary of Heath & Human Services Kathleen Sebelius discusses the benefits and challenges of implementing the Affordable Care Act or ‘Obamacare’ as the media has tagged last year’s healthcare legislation. As one TEDMED presenter pointed out last week in an unrelated (but compelling) video: “This is not healthcare reform; it’s heathcare finance reform”. Sebelius [...]
Read the full article →
February 2, 2012
Roche CEO Severin Schwan is bullish, stating “overall I am very pleased with our results, we achieved a solid performance, both of our businesses pharma and diagnostics are growing in a challenging environment and as far a profitability is concerned actually we increased profitability (in 2011)”. He does offer one comment during the interview about [...]
Read the full article →
February 1, 2012
Today, the House Committee on Energy and Commerce will begin debating the renewal of PDUFA. Technically, this is a reauthorization of the Prescription Drug User Fee Act IV (PDUFA), which is set to expire later this year. This bill will essentially mandate how FDA approves, regulates and funds its oversight of prescription drugs in the [...]
Read the full article →
February 1, 2012
After taking Amylin’s Bydureon approval down to the wire this weekend, the FDA has stepped up their approval notifications in the past two days. Amylin’s PFDUFA date was January 28th, a Saturday. When Friday afternoon came and went on the East Coast, many began wondering about the verdict. However, the FDA finally chimed in with [...]
Read the full article →
January 31, 2012
CEO Daniel Bradbury explains how Amylin will catch up with rival Novo Nordisk and pricing pressures for new diabetes treatments. Maria Bartiromo from CNBC asks all the right questions in her attempts to get to the core of Amylin’s strategy moving forward. As you would expect, Bradbury offers very little specifics or details on strategy, [...]
Read the full article →
January 30, 2012
This is an odd bit. On Youtube, you can find the home of Trustus Pharmaceuticals. The entire YT channel is devoted to a crude, if not clever, animation parody of a fictional pharmaceutical company. The company is described as “A collection of scientists, misfits, and corporate stooges at an imaginary pharmaceutical plant must deal with [...]
Read the full article →
January 30, 2012
FDA regulation and the forthcoming medical device excise tax remain significant issues for medical device makers. Now they have the attention of the President of the United States. President Barack Obama specifically mentioned medical devices in his State of the Union address on Wednesday, allowing AdvaMed to recognize the President’s comments. AdvaMed CEO Stephen J. [...]
Read the full article →
January 27, 2012
The premier medical device and technology event of the year, AdvaMed 2012: The MedTech Conference has officially launched its new website and opened the call for program panel proposals. Annually one of the strongest events of the year, Advamed 2012 will be held at the Boston Convention & Exhibition Center on October 1-3. More than [...]
Read the full article →
|
